- Home
- SRTS vs NSPR Comparison
SRTS vs NSPR Comparison
Compare SRTS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- NSPR
- Stock Information
- Founded
- SRTS 2010
- NSPR 2005
- Country
- SRTS United States
- NSPR United States
- Employees
- SRTS N/A
- NSPR N/A
- Industry
- SRTS Medical/Dental Instruments
- NSPR Medical/Dental Instruments
- Sector
- SRTS Health Care
- NSPR Health Care
- Exchange
- SRTS Nasdaq
- NSPR Nasdaq
- Market Cap
- SRTS 75.5M
- NSPR 74.8M
- IPO Year
- SRTS 2016
- NSPR N/A
- Fundamental
- Price
- SRTS $3.39
- NSPR $2.41
- Analyst Decision
- SRTS Strong Buy
- NSPR Strong Buy
- Analyst Count
- SRTS 3
- NSPR 2
- Target Price
- SRTS $8.00
- NSPR $4.50
- AVG Volume (30 Days)
- SRTS 211.1K
- NSPR 102.5K
- Earning Date
- SRTS 08-07-2025
- NSPR 08-05-2025
- Dividend Yield
- SRTS N/A
- NSPR N/A
- EPS Growth
- SRTS N/A
- NSPR N/A
- EPS
- SRTS N/A
- NSPR N/A
- Revenue
- SRTS $37,564,000.00
- NSPR $7,066,000.00
- Revenue This Year
- SRTS N/A
- NSPR $7.48
- Revenue Next Year
- SRTS $33.38
- NSPR $104.39
- P/E Ratio
- SRTS N/A
- NSPR N/A
- Revenue Growth
- SRTS 3.29
- NSPR 7.60
- 52 Week Low
- SRTS $3.03
- NSPR $1.99
- 52 Week High
- SRTS $9.33
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- SRTS 39.05
- NSPR 47.72
- Support Level
- SRTS $3.08
- NSPR $2.35
- Resistance Level
- SRTS $3.45
- NSPR $2.49
- Average True Range (ATR)
- SRTS 0.20
- NSPR 0.11
- MACD
- SRTS 0.01
- NSPR -0.01
- Stochastic Oscillator
- SRTS 82.00
- NSPR 30.77
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.